17th Euro Biotechnology Congress
Scope and Importance
Euro Biotechnology Conference aims to bring together the Professors, Researchers, scientists, business giants, and technocrats to provide an international forum for the dissemination of original research results, new ideas and practical development and discover advances in the field of biotechnology, management and education in relation to biotechnology as well as a breadth of other topics. The applications of biotechnology include therapeutics, diagnostics, genetically modified crops for agriculture, processed food, bioremediation, waste treatment, and energy production. Euro Biotechnology-2016 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.
Major topics discussed are Pharmaceutical Biotechnology, Biotechnology in Healthcare, Food Biotechnology, Industrial and Microbial Biotechnology, Plant Biotechnology, Agriculture Biotechnology, Animal Biotechnology, Environmental Biotechnology, Marine Biotechnology, Nanobiotechnology, Current Scenario of Biotechnology, Biomass and Bioenergy, Biotechnology and its Applications, Fighting Cancer with Biotechnology, Biotechnology Market, Biotech products, Biotech Companies and market analysis, Biotechnology investors and Grants, Advances in Biotech Manufacturing, Biotech investors network, biotech Market, latest biotech research.
Conferenceseries LLC Organizes 1000+ Global Events inclusive of 300+ Conference Series, 500+ Workshops and 200+ Symposiums Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50,000 eminent personalities, reputed scientists as editorial board members.
Conference Series Ltd
Heathrow Park Lakeside House, 1 Fuerzeground Way
Heathrow, UB11 1BD Uk
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 17th Euro Biotechnology Congress here
News-ID: 403500 • Views: 517
More Releases for Biotech
Global Ginkgetin Market 2019 - Hunan Nutramax, Shaanxi Pioneer Biotech, Xi'an So …
Ginkgetin is an extract from ginkgo biloba. Scope of the Report: Ginkgetin can dilate blood vessels, promote blood circulation, enhance immunity, and promote cerebral blood circulation and cell metabolism. The worldwide market for Ginkgetin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017. This report focuses on the Ginkgetin in global market, especially in North
Global Phycobiliprotein Market 2017 Norland Biotech, Algapharma Biotech, Phyco-B …
Global Phycobiliprotein Market Report 2017 Phycobiliprotein industrial chain, this report mainly elaborate the definition, types, applications and major players of Phycobiliprotein market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the
GLOBAL PHYCOBILIPROTEIN MARKET- DAINIPPON INK AND CHEMICALS, PHYCO-BIOTECH 2 COL …
Global Industry Study Evaluate on Phycobiliprotein Market by Type Manufacturers Regions and Application Forecast up to 2022 The scope of the Phycobiliprotein Report: This report primarily focuses on Phycobiliprotein in the global market. This report generally covers Phycobiliprotein market in North America Phycobiliprotein market in Asia-Pacific Phycobiliprotein market in Europe Phycobiliprotein market in Latin America Middle as well as Africa. This report partitions the Phycobiliprotein market based on Application Manufacturers Countries as
Harver Group Targets BioTech Bull
Synta Pharmaceuticals has a bullish outlook for Q3-Q4; insider buying indicates the company will be releasing positive research results and see a gain in returns. Jul. 24, 2013 - CHUO-KU, Japan -- Due to the huge increase in staff and board members buying stock in Synta Pharmaceuticals, and the successful trials of Synta Pharmaceuticals latest cancer drug Ganetespib, Pharmaceutical Analysts at Harver Group are now strongly recommending the stock as a
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Biotech APIs Showing Insurgent Growth
According to a new research report by RNCOS entitled, “Global Biotech API Market Analysis”, the rapidly growing and innovating biopharmaceuticals and biotechnology industry as a whole is putting the biotech API industry into charts of insurgent growth. Research Analysis & Highlights The report, “Global Biotech API Market Analysis”, spread over 55 pages, provides an in-depth research and rational analysis of the current and expected status of the biotech API industry across the